(Q34545094)

2 August 2017

Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats (English)

1 reference

2 August 2017

0 references

1 reference

3

Yasmin L Hurd

1 reference

2 August 2017

Maria Ellgren

1

1 reference

2 August 2017

Sabrina M Spano

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

5 July 2006

1 reference

2 August 2017

Neuropsychopharmacology

1 reference

2 August 2017

32

1 reference

2 August 2017

3

1 reference

2 August 2017

607-615

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301127

2 August 2017

0 references

cites work

A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Trajectories of brain development: point of vulnerability or window of opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Does cannabis use encourage other forms of illicit drug use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Restricted daily consumption of a highly palatable food (chocolate Ensure(R)) alters striatal enkephalin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Neural mechanisms of drug reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Opponent process model and psychostimulant addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Drug addiction, dysregulation of reward, and allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Escalation of drug use in early-onset cannabis users vs co-twin controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Training dose and session time as contextual determinants of heroin self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Prenatal Delta(9)-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Cannabinoid receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Incentive-sensitization and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

The adolescent brain and age-related behavioral manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Cannabis use and psychosis: a longitudinal population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Cannabis use and age at onset of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

Persistent increase in the motivation to take heroin in rats with a history of drug escalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

Psychomotor stimulant addiction: a neural systems perspective.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

Cannabis dependence and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

Opioids excite dopamine neurons by hyperpolarization of local interneurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

Morphine alters preproenkephalin gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

Patterns of drug use from adolescence to young adulthood: III. Predictors of progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301127

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301127

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference